Investor Information
Latest News
-
Indivior Announces Launch of SUBOXONE® (buprenorphine and naloxone) Sublingual Film Authorized Generic
February 20, 2019 | PDF Version
-
The Lancet Publishes Phase 3 Results Demonstrating Efficacy, Safety and Tolerability of SUBLOCADE™ (Buprenorphine Extended-Release) Injection for Subcutaneous Use (CIII) in Patients with Moderate to Severe Opioid Use Disorder (OUD)
February 19, 2019 | PDF Version
-
Presentation: Indivior FY 2018 Results Presentation (February 14)
February 14, 2019
-
Indivior PLC FY 2018 Financial Results
February 14, 2019 | PDF Version
Upcoming Events
-
FY 2018 Results Presentation on February 14ᵗʰ
Thursday, February 14th -
Stifel 2018 Healthcare Conference
November 13th -
Indivior Announces Upcoming Investor Events
November 6th, 2018 -
Nine Months Year-to-Date & Q3 2018 Results Webcast.
Thursday, November 1st -
Morgan Stanley Conference SUBLOCADE™ Update
September 12th -
Morgan Stanley 16th Annual Global Healthcare Conference
9/13/2018 -
H1 2018 Financial Results Presentation (July 25th)
July 25th -
Webcast Event: Jefferies 2018 Global Healthcare Conference, June 5th at 8:30 a.m. New York City time
June 5th -
2018 Annual General Meeting
May 16th -
Indivior PLC Q1 2018 Financial Results
May 2nd
See more
Webcasts/Audiocasts/Presentations
Click on the headings to view online or download a presentation:
RNS Filings
View Indivior filings with the Regulatory News Service on regulatory and non-regulatory updates.
